Current Committees

Program Committees

Advertising and Promotion Conference Planning Committee helps FDLI to provide timely and relevant programming regarding advertising and promotion trends, emerging issues, and policy developments. This conference is typically held in the fall.

  • Melissa Scales (Staff Liaison), FDLI
  • Madhavi Bellamkonda, Abbott Laboratories
  • Rebecca Burnett, Framework Solutions
  • Julie Chronis, Gilead Sciences, Inc.
  • Virginia Foley, Opus Regulatory, Inc.
  • Mark Gaydos, Sanofi
  • Bryant Godfrey, Arnold & Porter LLP
  • Matthew Hegreness, Covington & Burling LLP
  • Mark Levy, Eckert Seamans Cherin & Mellott, LLC
  • Thomas Miller, Nixon GWILT Law
  • Lauren Miller, Otsuka America Pharmaceutical, Inc.
  • Gillian Russell, King & Spalding LLP
  • Cassie Scherer, Medtronic
  • Victoria Tamarkin, Tamarkin Consulting LLC
  • Kyle Thomson, American Medical Association

Annual Conference Planning Committee helps plan and implement FDLI’s Annual Conference, the premier event of the food and drug law community. This conference is typically held in the spring.

  • Laura Brown (Staff Liaison), FDLI
  • Wade Ackerman, Covington & Burling LLP
  • David J. Bloch, Medtronic
  • Jeffrey B. Chasnow, Pfizer, Inc.
  • Sandra B. Eskin, Pew Charitable Trusts
  • Todd Halpern, GlaxoSmithKline
  • Erika F. Lietzan, (Co-Chair), University of Missouri-Columbia School of Law
  • Eric N. Lindblom, Georgetown University
  • Adora Ndu, BioMarin Pharmaceutical Inc.
  • Meredith Q. Olearchik, Campbell Soup Company
  • Beth G. Oliva, Fox Rothschild
  • Suzan Onel, Kleinfeld, Kaplan & Becker LLP
  • John M. Packman, DLA Piper LLP
  • Stuart M. Pape, (Co-Chair), Polsinelli
  • Veleka Peeples-Dyer, Baker McKenzie
  • Vernessa T. Pollard, McDermott Will & Emery
  • David C. Spangler, Consumer Healthcare Products Association
  • Marta L. Villaraga, Exponent, Inc.
  • Anne K. Walsh, Hyman, Phelps & McNamara, PC

California Programs Planning Committee helps FDLI identify pertinent topics and develop programming to be offered in California.

  • Khara Minter (Staff Liaison), FDLI
  • Afia Asamoah, Google Health
  • Alecia Cotton, Rogers, Joseph, O’Donnell, P.C.
  • Vinita Kailasanath, Arnold & Porter LLP
  • Abby Meyer, Sheppard Mullin Richter & Hampton LLP
  • Natalie Rainer, Keller and Heckman LLP
  • Amy Speros, Latham & Watkins LLP
  • Deborah Tolomeo, Genentech, Inc.

Enforcement, Litigation, and Compliance Conference Planning Committee helps FDLI cover the latest trends and changes in enforcement and compliance. This conference is typically held in the fall.

  • Laura Brown (Staff Liaison), FDLI
  • Hannah Bornstein, Nixon Peabody LLP
  • Adrienne Busby, Faegre Drinker Biddle & Reath LLP
  • Philip Crooker, Parexel International Corporation
  • Maya Florence, Skadden, Arps, Slate, Meagher & Flom LLP
  • Elizabeth Gallenagh, Healthcare Distribution Alliance (HDA)
  • William Gould, Holland & Knight LLP
  • Dennis Gucciardo, Morgan, Lewis & Bockius LLP
  • Stephanie Haggerty, Pfizer, Inc.
  • Bryan Haynes, Troutman Pepper Hamilton Sanders LLP
  • Winston Kirton, Winston & Strawn LLP
  • Peter Leininger, King & Spalding LLP
  • Donnelly McDowell, Kelley Drye & Warren LLP
  • Anne Miller, Medtronic
  • John Murphy, Biotechnology Innovation Organization
  • Bob Rhoades, Validant
  • Allen Sayler, EAS Consulting Group
  • Lora Spencer, Reed Smith LLP
  • William Stellmach, Willkie Farr & Gallagher LLP
  • Frances Zipp, Lachman Consultants

Food Advertising, Labeling, and Litigation Conference Planning Committee helps FDLI to provide updates on the most pertinent aspects and trends in advertising, labeling, and litigation. This conference is typically held in the fall.

  • Steven Leslie (Staff Liaison), FDLI
  • William Acevedo, Wendel Rosen LLP
  • Matthew Ball, K&L Gates LLP
  • Christopher Cole, Crowell & Moring LLP
  • Stefanie Fogel, DLA Piper LLP (US)
  • Dale Giali, Mayer Brown LLP
  • August Horvath, Foley Hoag LLP
  • Samuel Jockel, Alston & Bird LLP
  • Maia Kats, Kaplan Fox & Kilsheimer LLP
  • Karin Moore, Hyman, Phelps & McNamara, PC
  • Megan Olsen, Council for Responsible Nutrition
  • Christopher Van Gundy, Sheppard Mullin Richter & Hampton LLP
  • Kurt Weaver, Womble Bond Dickinson (US) LLP
  • Nury Yoo, Keller and Heckman LLP
  • Michael Roberts, UCLA School of Law
  • Lorie Foster, Abbott Nutrition

Food and Dietary Supplements Safety and Regulation Conference Planning Committee helps FDLI cover recent developments and looming challenges for product safety and regulation. The conference is typically held in the Spring

  • Steve Leslie (Staff Liason), FDLI
  • Steve Armstrong, Haynes and Boone, LLP
  • Ricardo Carvajal, Hyman, Phelps & McNamara, PC
  • Jackie Chan, Kleinfeld, Kaplan & Becker, LLP
  • Elizabeth Fawell, Hogan Lovells US LLP
  • Andrea Ferrenz,Campbell Soup Company
  • Neal Fortin, Michigan State University College of Law
  • Ryan Gooley, Stericycle
  • Elizabeth (Beth) Johnson, Food Directions LLC
  • Jensen Jose, Center for Science in the Public Interest
  • Heili Kim, Faegre Drinker Biddle & Reath LLP
  • Sarah Roller, Kelley Drye & Warren LLP

New to Food and Drug Law Planning Committee assists FDLI in creating educational programming and networking opportunities for those new to food and drug law.

  • Paige Samson (Staff Liaison), FDLI
  • Alexander V. Alfano, Axinn, Veltrop & Harkrider LLP
  • Brigid Bondoc, Sidley Austin LLP
  • Lauren Farruggia, Saul Ewing Arnstein & Lehr LLP
  • Rachel Goeriz, Exponent, Inc.
  • Maria Kalousi-Tatum, Morgan, Lewis & Bockius LLP
  • Anton Lesaca, Venable LLP
  • Stacey Pine, American Beverage Association
  • Matthew Piscitelli, Buchanan Ingersoll & Rooney PC
  • Daniel Stallone, Town of Davie Florida
  • Marc Wagner, BakerHostetler
  • Justin Waldrep, Sugaright
  • Sarah Catherine Copper, University of Arkansas
  • Jeanne Sun, U.S. Pharmacopeia
  • Jennifer Yoo, Foley Hoag LLP
  • Steven Gonzalez, Ropes & Gray LLP

Patient Organization Engagement Committee assists FDLI by creating innovative introductory course offerings for patient organizations.

  • Paige Samson (Staff Liaison), FDLI
  • David Fox, Hogan Lovells US LLP
  • Debra Lappin, Faegre Drinker Biddle & Reath LLP
  • Peter Pitts, Center for Medicine in the Public Interest
  • Deborah Shelton, Arent Fox LLP
  • Ami Simunovich, Becton Dickinson (BD)
  • Joshua Soreth-Harman, Sanofi
  • Kathryn Spates, The Joint Commission
  • Eva Temkin, FDA – CDER

Webinar Programs Committee advises FDLI in formulating and implementing webinars about law, regulation and policy affecting food and dietary supplements, tobacco and nicotine, and medical products.

  • Melissa Scales (Staff Liaison), FDLI
  • Khara Minter (Staff Liaison), FDLI
  • Jerry Appert, Compliance Architects LLC
  • Kalah Auchincloss, Greenleaf Health, Inc.
  • Nathan Beaver, Foley & Lardner LLP
  • Mitchell Berger, FDA – CBER
  • Vanessa Burrows, Simpson Thacher & Bartlett
  • Monica Groat, Latham & Watkins LLP
  • Elizabeth Guo, FDA – OC
  • Mark Hendrickson, Leavitt Partners, LLC
  • Thomas Lynch, CHF Solutions
  • Serra Schlanger, Hyman, Phelps & McNamara, PC
  • Steven Tjoe, Goodwin Procter LLP
  • Suzie Trigg, Haynes and Boone LLP
  • Saleh Turujman, FDA – CFSAN
  • Leonel Vanegas, San Diego State University
  • Cicely Vaughn, Walmart Inc.
  • Jacqueline Berman, Morgan, Lewis & Bockius LLP
  • George Serafin, FTI Consulting, Inc.
  • Frank Spano, Polsinelli PC
  • Brian Malkin, McDermott Will & Emery
  • Lori Hirsch, Bristol-Myers Squibb Company

Publications Committees

Austern Writing Awards Committee fosters the next generation of professionals in the food and drug law field.

  • Paige Samson (Staff Liaison), FDLI
  • Khelin N. Aiken, Baker McKenzie
  • Nathan Beaton, Latham & Watkins LLP
  • Barbara Binzak Blumenfeld, Buchanan Ingersoll & Rooney PC
  • Brendan Carroll, Alston & Bird LLP
  • Christopher Fanelli, Hogan Lovells US LLP
  • Joshua Oyster, Ropes & Gray LLP
  • Jordan Paradise, Loyola University
  • Gail Pilgrim, Temple University
  • Mital Patel, Foley Hoag LLP
  • Melissa Runsten, Debevoise & Plimpton LLP
  • Mariam Sarwar, Crowell & Moring LLP

Food and Drug Law Journal Editorial Advisory Board provides peer review of manuscript submissions, advises on content, and serves as a resource for our student editors at Georgetown University Law Center.

  • Paige Samson (Staff Liaison), FDLI
  • Laurie Beyranevand, Vermont Law School
  • Jennifer Black, FDA – OC
  • Marie Boyd, University of South Carolina
  • Nathan Brown, Akin Gump Strauss Hauer & Feld LLP
  • Christine P. Bump, Penn Avenue Law & Policy
  • Jonathan Cohen, K&L Gates LLP
  • Bridget C. E. Dooling, George Washington University
  • Javier González-Rivera, Emory University
  • Lewis A. Grossman, American University
  • Peter Barton Hutt, Covington & Burling LLP
  • William Janssen, Charleston School of Law
  • John Johnson, Shook, Hardy & Bacon LLP
  • Alan C. Katz, toXcel, LLC
  • Sara Wexler Koblitz, Hyman, Phelps & McNamara, PC
  • Marian J. Lee, Gibson Dunn & Crutcher LLP
  • Priya Mannan, Novartis Pharmaceuticals Corporation
  • Eileen McMahon, Torys LLP
  • Cynthia L. Meyer, Kleinfeld, Kaplan & Becker, LLP
  • J.R. McNair, Winston & Strawn LLP
  • Alan Minsk, Arnall Golden Gregory LLP
  • Anne Marie Murphy, Consumer Healthcare Products Association (CHPA)
  • James O’Reilly, University of Cincinnati
  • Daniel Orr, Thomson Reuters
  • Jessica Ringel, King & Spalding LLP
  • Tyler Scandalios, FDAImports.com, LLC/ Benjamin L. England & Associates LLC
  • Marc Scheineson, Alston & Bird LLP
  • Shy Shorer, National Institutes of Health
  • Anna Sims, FDA – OC
  • Eric Solowey, Parexel International Corporation
  • Genevieve Spires, Buchanan Ingersoll & Rooney PC
  • Emily Wright, Pfizer, Inc.
  • Paige Samson (Staff Liaison), FDLI
  • Kenita Barrow, Otsuka America Pharmaceutical, Inc.
  • Ralph Hall, University of Minnesota
  • Joanne Hawana, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Laurie Lenkel, FDA – OC
  • Elizabeth Richards, Latham & Watkins LLP

Publications Peer Review Committee provides manuscript review and editorial feedback for Update magazine, electronic resources, and book chapters.

  • Paige Samson (Staff Liaison), FDLI
  • David Abramowitz, Locke Lord LLP
  • Alena Allen, University of Memphis
  • Daren Bakst, The Heritage Foundation
  • Royce DuBiner, McGuireWoods LLP
  • Ben Firschein, Congressional Research Service
  • Jonathan Gil, Pfizer, Inc.
  • R. Frederic Henschel, Potomac Law Group
  • Emily Hussey, Reed Smith LLP
  • Victor Krauthamer
  • Areta Kupchyk, Foley Hoag LLP
  • Dan Logan, Kleinfeld, Kaplan & Becker, LLP
  • Brandon Moss, Wiley LLP
  • Jarred L. Reiling, King & Spalding LLP
  • Stephanie Resnik, Covington & Burling LLP
  • David Simon, George Washington University Law School
  • Andrew Wasson, Haug Partners LLP

Product Area Committees

Cannabis-Derived Products Committee assists FDLI with developing content and identifying stakeholders to contribute to the discussion of cannabis-derived products in the federal regulatory space.

  • Melissa Scales (Staff Liaison), FDLI
  • Karen Balderama, Wendel Rosen LLP
  • Tina Beamon, Karyopharm Therapeutics
  • Rodney Butt, Nutrasource Pharmaceutical & Nutraceutical Services
  • Katherine Ciambrone, Cresco Labs
  • Tara Couch, EAS Consulting Group
  • Delia Deschaine, Epstein Becker & Green, PC
  • Samantha Dietle, Hogan Lovells US LLP
  • William Garvin, Buchanan Ingersoll & Rooney PC
  • Kate Hardey, McGuireWoods LLP
  • Jonathan Havens, Saul Ewing Arnstein & Lehr LLP
  • Keith Matthews, Wiley LLP
  • Deborah Miran, DMiran Consulting
  • Heike Newman, University of Colorado
  • Daniel Rubenstein, Steptoe & Johnson LLP
  • Juan Luis Serrano-Leets, Sánchez Devanny
  • Howard Sklamberg, Arnold & Porter LLP
  • Frederick Stearns, Keller and Heckman LLP
  • Justin Stern, Duane Morris LLP
  • Thomas Tobin, Perkins Coie LLP

Medical Products Committee helps FDLI provide programming to meet the needs of the medical products community.  

  • Melissa Scales (Staff Liaison), FDLI
  • Nicholas Benetatos, Exponent, Inc.
  • Robert Berlin, FDA – CDER
  • Shelby Buettner, FDA – OC
  • Mantej Chhina, BioMarin Pharmaceutical Inc.
  • Bryan Coleman, EAS Consulting Group
  • Jennifer Devine, U.S. Pharmacopeia
  • Brian Eckman, Genentech, Inc.
  • Lynne Ensor, Parexel International Corporation
  • Allison Fulton, Sheppard Mullin Richter & Hampton LLP
  • Colleen Heisey, Jones Day
  • Carmine Jabri, E.M.M.A. International Consulting Group, Inc.
  • Chad Landmon, Axinn, Veltrop & Harkrider LLP
  • Scott Lassman, Lassman Law + Policy
  • Gregory Levine, Ropes & Gray LLP
  • Davina Marano, FDA – CDRH
  • Christina Mooney, Medtronic
  • Lidia Niecko-najjum, Crowell & Moring LLP
  • Sung Park, Reed Smith LLP
  • Schevon Salmon, Otsuka America Pharmaceutical, Inc.
  • Kathleen Sanzo, Morgan, Lewis & Bockius LLP
  • Marinka Tellier, NSF International

Tobacco and Nicotine Products Committee ensures that tobacco programs bring diverse stakeholders together to have high-level discussions on tobacco products regulation and policy.

  • Steven Leslie (Staff Liaison), FDLI
  • Jasjit Ahluwalia, Brown University
  • Lindsay Andrews, JUUL Labs
  • Scott D. Ballin, Public Health Consultant
  • James Baumberger*, American Academy of Pediatrics
  • Aruni Bhatnagar*, University of Louisville
  • Azim Chowdhury, Keller and Heckman LLP
  • K. Michael Cummings, Medical University of South Carolina
  • Brittani Cushman, Turning Point Brands, Inc.
  • Clifford Douglas*, University of Michigan
  • Stacy Ehrlich, Kleinfeld, Kaplan & Becker, LLP
  • Brian Eric Erkkila, Foundation for a Smoke-Free World
  • Stacey Younger Gagosian, Truth Initiative
  • Thomas Glynn, Stanford University
  • Robyn Gougelet, Pinney Associates, Inc.
  • Dennis Henigan*, Campaign for Tobacco-Free Kids
  • Desmond Jenson*, Public Health Law Center – Tobacco Control Legal Consortium
  • Eshael Johnson, FDA – CTP
  • Rima Khoury, Fumari, Inc.
  • Ondrej Koumal, Philip Morris International
  • John Marshall, Altria Client Services LLC
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • John Pritchard, 22nd Century Group, Inc.
  • Agustin Rodriguez, Troutman Pepper Hamilton Sanders LLP
  • Henry Roemer, Finger, Roemer, Brown & Mariani LLP
  • Barry Schaevitz, Fox Rothschild LLP
  • Jim M. Solyst, Swedish Match North America
  • Mark J. Vaders, Womble Bond Dickinson (US) LLP
  • Benjamin K. Wolf, Alston & Bird LLP

* Public Health Subcommittee

  • Melissa Scales (Staff Liaison), FDLI
  • Neal Bataller, CVM, FDA
  • Grace Gowda, University of Georgia
  • Nancy E. Halpern, Fox Rothschild LLP
  • Jeannie M. Perron, Covington & Burling LLP
  • Elizabeth B. Stutts, Hancock, Daniel & Johnson
  • Ashley Morgan, American Veterinary Medical Association

Governance Committees

Audit Committee oversees and evaluates the management’s control over financial reporting. This committee is led by and reports to the FDLI Board of Directors. 

  • Hayley Carpenter (Staff Liaison), FDLI
  • Cathy Burgess (Chair), Alston & Bird LLP
  • Neil P. Di Spirito, Epstein Becker & Green, PC
  • Jonathan Havens, Saul Ewing Arnstein & Lehr LLP
  • Stuart Pape, Polsinelli PC

Black Lives Matter Advisory Group advises FDLI on substantive and programmatic issues relevant to diversity, equity, and inclusion with a focus on promoting greater representation of Black professionals in the food and drug law community.

  • Elizabeth H. Anderson, Anderson & Associates, LLC
  • Oluwaseun (Kemi) Asante, FDA – CDER
  • Shamina Aubuchon, Altria Client Services LLC
  • Alundai Benjamin, University of Connecticut
  • Jennifer Bragg, Skadden, Arps, Slate, Meagher & Flom LLP
  • Noni L. Ellison, Carestream Dental LLC
  • Iris Gibbs, Karyopharm Therapeutics
  • Melanie Katrice Gross, Greentech, Inc.
  • Janet Johnson, Terumo BCT, Inc.
  • Dan Kracov, Arnold & Porter LLP
  • Anthony Lee, FDA – CFSAN
  • Valerie B. Marshall, FDA – CBER
  • Flora Chinyere Okereke, RAI Service Company (RAISC)
  • Sarah Thompson Schick, DLA Piper LLP (US)
  • LieAnn Van-Tull, Keller and Heckman LLP
  • Jeffrey N. Wasserstein, Hyman, Phelps & McNamara, PC
  • John (Barr) Weiner, FDA – OC
  • Patti Zettler, The Ohio State University

Finance Committee oversees FDLI’s financial affairs, including budget formulation and execution, and investment portfolio management. This committee is led by and reports to the FDLI Board of Directors. 

  • Hayley Carpenter (Staff Liaison), FDLI
  • Frederick R. Ball (Chair), Duane Morris LLP
  • Jeffrey Francer (Board Liaison), Association for Accessible Medicines
  • Jeffrey Gibbs, Hyman, Phelps & McNamara, PC
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Peter Pitts, Center for Medicine in the Public Interest
  • Stuart TenHoor, Stuart TenHoor Legal Search

Questions?

[email protected]
202-222-0910